Trial Profile
Phase IIA Window Study of Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Myeloid leukaemia
- Focus Therapeutic Use
- 12 Aug 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 27 May 2009 Actual end date (Apr 2009) and actual patient number (1) added as reported by ClinicalTrials.gov.
- 27 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.